Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... between rosuvastatin and atorvastatin in the reduction of ESR, Hs-CRP or TLC. After 3 months rosuvastatin ..."
 
Vol 7, No 4 (2011) USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING Abstract  similar documents
A. T. Abdrashitova, T. N. Panova, I. A. Belolapenko, M. V. Frenkel
"... immunoassay were performed before treatment start and after 18 months of rosuvastatin taking. Results ..."
 
Vol 18, No 5 (2022) The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case Abstract  similar documents
O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova
"... , significant increases in creatine kinase (CK), myoglobin and creatinine. One month before that, she ..."
 
Vol 10, No 5 (2014) EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova
"... of the investigated parameters the individual doses of rosuvastatin were adjusted from 10 to 40 mg/day after 1 month ..."
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... , and after 1 month while taking rosuvastatin – 4.89±0.81 mmol/l (p<0.001). The change of TC level was -22% (p ..."
 
Vol 16, No 5 (2020) Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
"... and rosuvastatin in an individually prescribed dose. After 1 month (B1), if the target level of lowdensity ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... on rosuvastatin. Data of recent metaanalysis regarding statins efficacy in primary and secondary prevention ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin ..."
 
Vol 14, No 4 (2018) Statin Therapy and Cognitive Impairment: Benefit or Harm? Abstract  similar documents
O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova
"... and reducing the risk of potential cognitive impairment during statin therapy. Rosuvastatin may be safer ..."
 
Vol 13, No 2 (2017) COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH Abstract  similar documents
O. M. Drapkina
"... -lowering therapy with rosuvastatin, and to assess the level of satisfaction of doctors with the efficacy ..."
 
Vol 13, No 3 (2017) TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 Abstract  similar documents
O. M. Drapkina, A. S. Luishuta
"... , including its combinations, and rosuvastatin in real clinical practice. Material and methods. Analysis ..."
 
Vol 8, No 5 (2012) LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS Abstract  similar documents
A. N. Meshkov
"... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..."
 
Vol 14, No 3 (2018) THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova
"... иных клинических проявлений атеросклероза. Подробно описаны схемы назначения и предпочтительные дозы ..."
 
Vol 18, No 2 (2022) The problem of choice: original drug or generic? Emphasis on rosuvastatin Abstract  similar documents
O. A. Polyakova, O. D. Ostroumova
"... is described by the example of such a hypolipidemic agent as rosuvastatin. According to numerous studies ..."
 
Vol 16, No 2 (2020) Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG Abstract  similar documents
O. V. Fedorishina, K. V. Protasov, A. M. Torunova
"... antihypertensive therapy and additionally rosuvastatin (20 mg/day). The follow-up period was 52 weeks. The effect ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... .5%, whereas prescription of atorvastatin and rosuvastatin increased from 31.4% to 64.5% and from 3.6% to 9 ..."
 
Vol 18, No 4 (2022) Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review Abstract  similar documents
S. R. Gilyarevsky, M. V. Golshmid, N. G. Bendeliani
"... and rosuvastatin on blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) in hypertensive patients ..."
 
Vol 5, No 2 (2009) OBSERVATIONAL TRAILS IN LIPIDOLOGY Abstract  similar documents
S. A. Shalnova
 
Vol 7, No 1 (2011) ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? Abstract  similar documents
L. N. Malay
"... Clinical cases of long-term use of rosuvastatin are presented with an estimation of its effect ..."
 
Vol 8, No 3 (2012) STATINS AND MYOPATHY: MOLECULAR MECHANISMS Abstract  similar documents
O. M. Drapkina, E. M. Chernova, O. N. Korneeva
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... perindopril,rosuvastatin and fixed-dose combination of perindopril and indapamide, in ambulatory patients ..."
 
Vol 17, No 4 (2021) Epidemiological Observational Study on the Assessment of the Comorbidity and the Efficacy of the Treatment of Hypertensive Patients with Single Pill Combination of Lysinopril, Amlodipine and Rosuvastatin "PHENOTYPE-AG" Abstract  similar documents
M. P. Savenkov, S. N. Ivanov, M. V. Borschevskaya, I. N. Okuneva, S. V. Ivanova, A. M. Savenkova, R. V. Dushkin
"... , amlodipine and rosuvastatin (SPC LAR) in hypertensive patients. Material and methods. Observational ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... the benefits of rosuvastatin in the prevention and treatment of cardiovascular diseases are presented. ..."
 
Vol 21, No 2 (2025) A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol Abstract  similar documents
K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova
"... pitavastatin at a starting dose of 1 mg/day. Group 2 (n=75) will receive rosuvastatin 20 mg/day. After 3 months ..."
 
Vol 21, No 3 (2025) Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry Abstract  similar documents
I. A. Alekseeva, U. V. Chubykina, M. V. Ezhov, A. V. Tyurina, T. E. Kolmakova, N. A. Tmoyan, A. A. Sokolov, T. A. Rozhkova, N. S. Kurochkina, I. V. Sergienko, I. V. Avdeeva, V. E. Oleynikov, A. S. Alieva, N. G. Androsyuk, M. A. Kiselevа, Yu. G. Grigorieva, A. S. Asekritova, E. S. Kylbanova, A. V. Pavlova, A. I. Ershova, A. N. Meshkov, V. I. Mikhailina, A. V. Blokhina, A. S. Limonova, O. V. Kopylova, A. S. Vorobyev, I. D. Astrakhantseva, Yu. A. Vorobyeva, Yu. A. Ermakova, D. I. Sadykova, E. S. Slastnikova, L. F. Galimovа, I. I. Shaposhnik, V. V. Genkel, A. V. Egorova, N. V. Mukha, P. V. Vasilenko, D. N. Zaitsev, Z. F. Kim, V. K. Zafiraki, M. V. Zykov, V. A. Korneva, T. Yu. Kuznetsova, Yu. A. Malyshenko, T. I. Petelina, E. V. Mikova, A. M. Namitokov, E. D. Kosmacheva, I. I. Pshenichnikova, V. O. Konstantinov, S. E. Bednova, M. I. Voevoda, O. V. Timoshenko, Yu. I. Ragino, A. E. Filippov, A. M. Tuktarov, V. S. Gurevich, M. V. Muzalevskaya, S. A. Urazgildeevа, R. A. Khokhlov, S. V. Yarkovaya, E. A. Shutemova, E. V. Kudelkina, N. N. Bizyaeva
"... ) of rosuvastatin with ezetimibe, as well as the frequency of achieving target low-density lipoprotein cholesterol ..."
 
Vol 3, No 5 (2007) WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”? Abstract  similar documents
S. R. Gilyarevsky
"... Whether the study on efficacy of rosuvastatin in elderly patients with heart failure and systolic ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... – about 4,374 rubles a month. The most expensive original medicine was also rosuvastatin – about 4 ..."
 
Vol 16, No 4 (2020) Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice Abstract  similar documents
D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan
"... atorvastatin (10-80 mg/day) or rosuvastatin (10-40 mg/day). Group 1 patients had visits to the doctor after 1 ..."
 
Vol 17, No 1 (2021) Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits Abstract  similar documents
S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan
"... atorvastatin (10-80 mg/day) or rosuvastatin (10- 40 mg/day). Group 1 patients had visits to the doctor after 1 ..."
 
Vol 11, No 4 (2015) EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION Abstract  similar documents
I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov
"... months of observation. Material and methods. The study included patients with early RA (n=66; 71% women ..."
 
Vol 13, No 6 (2017) SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS Abstract  similar documents
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova
"... ) and 36 postmenopausal women (mean age 65±9.3 years). Patients were on statin therapy at least 6 months ..."
 
Vol 19, No 2 (2023) Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) Abstract  similar documents
M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov
"... .2% of cases, free combination of rosuvastatin with ezetimibe – in 17.2%, single pill combination ..."
 
Vol 6, No 3 (2010) THE SPECIFIC FEATURES OF HEART AND VESSELS REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH LISINOPRIL DURING 6 MONTHS Abstract  similar documents
N. A. Kosheleva, A. P. Rebrov
"... -month combined therapy with lisinopril on the heart and vessels remodeling in patients with ischemic CHF ..."
 
Vol 8, No 1 (2012) THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov
"... Aim. To estimate in a 12-month study mortality and frequency of recurrent cardiovascular events ..."
 
Vol 14, No 5 (2018) Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) Abstract  similar documents
G. S. Krasnov, I. V. Kazancev
"... +rosuvastatin, warfarin+amiodarone. It was found that the patient had not taken rosuvastatin before ..."
 
Vol 9, No 4 (2013) EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov
"... Aim. To evaluate in open 12 month prospective, randomized study the mortality and recurrent ..."
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..."
 
Vol 17, No 2 (2021) The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... vary from 12 weeks to 6 months. One of the most severe consequences of COVID- 19 is the defeat ..."
 
Vol 18, No 3 (2022) Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER Abstract  similar documents
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk
"... groups: group 1 (n=64) received a single pill combination of lisinopril + amlodipine + rosuvastatin; 2 ..."
 
Vol 15, No 6 (2019) Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice Abstract  similar documents
D. A. Napalkov
"... /perindopril, amlodipine/indapamide/perindopril and rosuvastatin in patients with hypertension and high/very ..."
 
Vol 18, No 1 (2022) Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova
"... .2-5.3 (p<0.001). Doctors preferred atorvastatin in prescriptions (n=456, 55.4%), rosuvastatin (n=244 ..."
 
Vol 16, No 5 (2020) Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy? Abstract  similar documents
Z. D. Kobalava, E. V. Kokhan
"... combination of indapamide, perindopril and rosuvastatin, the requirements for fixed drug combinations ..."
 
Vol 10, No 2 (2014) CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... 200 mg/day during 6 months for SR maintenance (group 1) or bisoprolol 5 mg daily for ventricular rate ..."
 
Vol 8, No 5 (2012) POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov
"... Aim. To identify possible predictors of atrial fibrillation (AF) recurrence in 6-month ..."
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... not receive hypolipidemic pharmacotherapy for a month before the study start. The patients were randomized ..."
 
Vol 9, No 6 (2013) DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi
"... mg daily during 6 months for SR maintenance (group 1) or bisoprolol 5 mg daily for ventricular rate ..."
 
Vol 3, No 5 (2007) EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
"... of antiarrhythmic drug withdrawal. During 3 months all patients received by turns two types of therapy: combination ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... осложнений. Рассмотрены эффективность и безопасность терапии высокими дозами аторвастатина. Показано, что ..."
 
Vol 13, No 2 (2017) POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER Abstract  similar documents
Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina
"... , routine laboratory tests were performed in all patients initially and after 1, 3, 6 and 12 months. All ..."
 
Vol 6, No 3 (2010) QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY Abstract  similar documents
A. V. Susekov, V. A. Bulatov, A. V. Vigdorchik
"... ; adverse events and serious adverse events. Observation period is planned for 6 months. During this period ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... . The combined endpoint (after 6 and 12 months) included cardiovascular death, recurrent nonfatal myocardial ..."
 
Vol 16, No 6 (2020) Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment Abstract  similar documents
V. Yu. Kopylov
"... .36±2.65 ncat/1 14.1±5.23 ncat/1 and after 3 and 6 months, LAAP - 9.4±1.62 and 11.2±2.99 ncat/1 after 3 ..."
 
Vol 18, No 2 (2022) Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva
"... were randomized into two groups: group I (n=60) included patients who, for 6 months after discharge ..."
 
Vol 17, No 3 (2021) Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects Abstract  similar documents
P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina
"... of three components (lisinopril, amlodipine and rosuvastatin), each of which has pleiotropic effects ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... with rosuvastatin. Target level of total cholesterol (<4 mmol/L) was achieved in 2.04-7.38% of the patients ..."
 
Vol 4, No 1 (2008) EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE Abstract  similar documents
S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash
"... months of therapy. Results. Good and satisfactory antihypertensive effect was achieved in 75 ..."
 
Vol 9, No 3 (2013) INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina
"... with muscle symptoms received statins significantly longer (48.8 vs 11.9 months, р<0.0001) and in higher doses ..."
 
Vol 2, No 4 (2006) ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva
"... that 6 month enalapril treatment resulted in significant improvement of disturbed function of vascular ..."
 
Vol 3, No 4 (2007) THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE Abstract  similar documents
I. V. Sergienko, M. E. Bugriy, T. V. Balahonova, G. A. Tkachev, V. B. Sergienko
"... into the study. 30 patients of the main group received mildronate at a daily dose of 1000 mg during 3 months ..."
 
Vol 9, No 1 (2013) ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM Abstract  similar documents
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok
"... 1 — intermittent treatment with meldonium (500 mg once daily for 3 months followed by a break 3 ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... 6 months of combined treatment with atorvastastin 20 mg/day depending on the disease duration ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
"... month of treatment isosorbide- 5-mononitrate and nebivolol reduced a number of angina episodes vs ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS Abstract  similar documents
O. L. Barbarash, M. V. Zykov
"... hypertensive patients had diabetes mellitus (DM). Study duration was 2 months. All patients started monotherapy ..."
 
Vol 5, No 5 (2009) LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE Abstract  similar documents
M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova
"... Aim. To estimate cardiorenoprotective effect of 12-month therapy by indapamide in elderly ..."
 
Vol 3, No 5 (2007) CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich
"... Amlorus and Norvasc, respectively. Cost of Amlorus therapy per patient was 221 rbl/month in comparison ..."
 
Vol 19, No 6 (2023) Endovenous laser ablation of great saphenous vein and pharmacotherapy of acute ascending thrombophlebitis: results of a three-month follow-up Abstract  similar documents
K. A. Kaperiz, A. O. Rastatueva, I. S. Yavelov, O. M. Drapkina
"... large tributaries, assess the incidence of venous thrombosis progression over 3 months with 1,5-month ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
 
Vol 7, No 6 (2011) ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS Abstract  similar documents
L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo
"... with the hematological analyzer . All investigations were performed in IHD patients before and after 2 months ..."
 
Vol 17, No 3 (2021) The Effect of Clinical Characteristics and Stent Parameters on Left Ventricular Mechanical Dyssynchrony Abstract  PDF (Eng)  similar documents
S. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk
"... -eluting stent. Patients were evaluated pre PCI then 1 month and 3 months post PCI for evaluation ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... mg QD. The duration of the study was 6 months. Results. In 4 weeks of the treatment systolic ..."
 
Vol 8, No 2 (2012) QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL Abstract  similar documents
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts
"... ) questionnaire after international clinical trial living or hospital discharge (initially) and in 3, 6 months ..."
 
Vol 1, No 3 (2005) PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE Abstract  similar documents
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova
"... in these patients during 6-month antihypertensive and hypolipidemic therapy. Material and methods: 24 women with AH ..."
 
Vol 6, No 6 (2010) EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) Abstract  similar documents
T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov
"... period was 13.14 months (min 1 month, max 36 months). Patients with arrhythmia relapse <48 h received ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... (63,8%). Значимых различий между группами в назначении суточных доз препаратов основных ..."
 
Vol 7, No 4 (2011) SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS Abstract  similar documents
E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts
"... Цель. Изучить взаимосвязь клинических характеристик и деталей индивидуального подбора дозы ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... стандартной дозами клопидогрела на агрегацию тромбоцитов, воспаление и функцию эндотелия у больных, перенесших ..."
 
Vol 17, No 2 (2021) Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions Abstract  similar documents
V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto
"... фибрилляцией предсердий (ФП) в реальной амбулаторной клинической практике в дозах, рекомендованных и не ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF AMLODIPINE MALEATE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIAL ASTHMA WITH CONCOMITANT ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Karoli, A. P. Rebrov, A. A. Roshchina, V. A. Sergeeva, E. E. Arkhangelskaya
"... ) was performed initially and in 6 months of treatment. Results. The high efficacy of amlodipine maleate ..."
 
Vol 3, No 1 (2007) DIZZINESS OF ISCHEMIC GENESIS: DESCRIPTION OF VESTIBULAR DISORDERS AND POSSIBILITY OF THERAPY Abstract  similar documents
N. S. Alekseeva
"... of 48 mg was held during 2 months. Results. Dysfunction of both peripheral and central parts ..."
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... , Russia) 10mg/day). HRV was compared before and after 3 months of therapy in both groups. Results ..."
 
Vol 8, No 4 (2012) THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova
"... and the work capacity were assessed at baseline and after 2 months of the drugs taking, as well as 2 months ..."
 
Vol 16, No 3 (2020) The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention Abstract  PDF (Eng)  similar documents
Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk
"... months after PCI using speckle tracking echocardiography. Results. Before revascularization, mean left ..."
 
Vol 19, No 1 (2023) Analysis of The Use of PCSK9 Inhibitors in Clinical Practice Abstract  similar documents
S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya
"... studied/ Results. The long-term use of alirocumab  (on average 7,5±2,3 months) is well tolerated without ..."
 
Vol 2, No 3 (2006) HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
L. I. Markova, A. I. Radzevich
"... 6 months. Hemodynamics was estimated by ambulatory BP monitoring, Doppler Echocardiography ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... months of therapy by clinical condition evaluated scale (CCES), 6-minute walking test, left ventricular ..."
 
Vol 6, No 3 (2010) EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS Abstract  similar documents
S. G. Dzugkoev, V. A. Metelskaya, I. V. Mozhaeva, F. S. Dzugkoeva
"... under 1 month administration of ubichinon compositum (0,11 mg/100g of body weight). Results ..."
 
Vol 3, No 4 (2007) EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. L. Hohlov, M. I. Shunikova, A. Yu. Sosnin, I. N. Kagramanyan, L. A. Lisenkova
"... on reactive hyperemia and nitroglycerine were conducted before and after 6 months of therapy. Results ..."
 
Vol 16, No 6 (2020) An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? Abstract  similar documents
T. V. Pavlova
"... evaluated in the XANTUS POOLED program. According to the follow-up results for 12 months, more than 96 ..."
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... assessed. Results. Calcium-phosphorus metabolism indices improved after 6 months of cinacalcet therapy ..."
 
Vol 2, No 2 (2006) THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM Abstract  similar documents
I. G. Fomina, N. A. Galanina, Z. O. Georgadze, N. E. Gaidamakina
"... and after 6 months of therapy myocardial contractile function of left and right ventricles was studied ..."
 
Vol 13, No 2 (2017) STUDY OF THE PARAMETERS OF TOLERABILITY AND ADHERENCE TO THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION ON THE BACKGROUND OF TREATMENT WITH FIXED COMBINATION OF RAMIPRIL AND AMLODIPINE (ACCORDING TO THE RESULTS OF OBSERVATIONAL STUDY "GRANAT-2") Abstract  similar documents
S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zakharova, O. V. Lerman, A. A. Garganeyeva, T. A. Gomova, S. A. Drozdetsky, A. I. Chesnikova
"... months. The Morisky-Green test was used to assess an adherence of patients to treatment. Assessments ..."
 
Vol 8, No 3 (2012) CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova
"... , exercise tolerance test were performed at baseline, after 6 and 9 months. Results. The long-term CPT ..."
 
Vol 17, No 5 (2021) A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases Abstract  PDF (Eng)  similar documents
Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva
"... and the beneficial effect on the body of constant intake of statins. After 1 and 3 months after discharge from ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..."
 
Vol 6, No 4 (2010) MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION Abstract  similar documents
Z. M. Sizova, E. V. Shikh, V. L. Zakharova, E. V. Smirnova
"... (n=15) — amlodipine 10 mg QD. The study duration was 3 months. The efficiency evaluation was based ..."
 
Vol 17, No 2 (2021) Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma Abstract  similar documents
G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya
"... without BA, the second - with AH + BA. The study consisted of three visits (first visit, 6 months and 12 ..."
 
Vol 4, No 5 (2008) TREATMENT OF COGNITIVE DISORDERS IN HYPERTENSIVE PATIENTS EXPOSED TO RADIATION Abstract  similar documents
I. V. Podsonnaja, G. G. Efremushkin, V. A. Golovin
"... of treatment as well as 6 and 12 months after treatment. Results. Cortexin therapy (2 courses) increased ..."
 
Vol 10, No 1 (2014) CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN Abstract  similar documents
N. A. Karoli, G. R. Dolishnya, A. P. Rebrov
"... =23), who have been receiving valsartan with starting dose 80 mg/day for 6 months as antihypertensive ..."
 
Vol 3, No 2 (2007) CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS Abstract  similar documents
V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina
"... of apoptosis processes were registered according to growth of CCP severity. After 6 months of therapy von ..."
 
1 - 100 of 566 Items 1 2 3 4 5 6 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)